The purpose of this study is to evaluate immunological efficacy and safety of GC3110A among healthy adults over 65 years of age.
Adults over 65 years of age will be once administered GC3110A(Quadrivalent influenza vaccine).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
274
0.5mL, Intramuscular
The Catholic Univ. of Korea Daejeon St.Mary's Hospital
Daejeon, South Korea
Soon Chun Hyang University Bucheon Hospital
Gyeonggi-do, South Korea
The Catholic Univ.of Korea Bucheon St.Mary's Hospital
Gyeonggi-do, South Korea
Percentage of Participants Achieving Pre-defined Seroconversion Before and following vaccination
Percentage of Participants Achieving Pre-defined Seroconversion Before and following vaccination
Time frame: Day 0 (Pre-Vaccination) and Day 21 (Post-Vaccination)
Percentage of Participants Achieving Pre-defined Seroprotection Before and following vaccination
Percentage of Participants Achieving Pre-defined Seroprotection Before and following vaccination
Time frame: Day 0 (Pre-Vaccination) and Day 21 (Post-Vaccination)
Geometric Mean Titer and Geometric Mean Titer Ratios of Antibodies to the GC3110A Before and Following Vaccination
Geometric Mean Titer and Geometric Mean Titer Ratios of Antibodies to the GC3110A Before and Following Vaccination
Time frame: Day 0 (Pre-Vaccination) and Day 21 (Post-Vaccination)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Catholic Univ.of Korea Uijeongbu St.Mary's Hospital
Gyeonggi-do, South Korea
EWHA woman's university mokdong hospital
Seoul, South Korea
KyungHee University Medical Center
Seoul, South Korea
Soon Chun Hyang University Seoul Hospital
Seoul, South Korea
The Catholic Univ. of Korea Incheon St.Mary's Hospital
Seoul, South Korea
The Catholic Univ.of Korea Seoul St.Mary's Hospital
Seoul, South Korea
The Catholic Univ.of Korea Yeouido St.Mary's Hospital
Seoul, South Korea